Literature DB >> 18067551

Association of F11 receptor gene polymorphisms with central obesity and blood pressure.

K L Ong1, R Y H Leung, L Y F Wong, S S Cherny, P C Sham, T H Lam, K S L Lam, B M Y Cheung.   

Abstract

OBJECTIVES: F11 receptor, also known as junctional adhesion molecule-1, in the autonomic nervous system is implicated in the development of hypertension in spontaneous hypertensive rats. We investigated the association of single nucleotide polymorphisms (SNPs) in the F11 receptor gene (F11R) with hypertension and central obesity in Hong Kong Chinese.
METHODS: Seven tagging SNPs were identified in the HapMap database. Genotyping was performed using Sequenom MassArray in 263 hypertensive subjects and 393 normotensive controls, of whom 263 matched the cases in age and sex.
RESULTS: When subjects on anti-hypertensive medication were excluded, rs790056 and rs2774276 were associated with lower systolic blood pressure (TT:124.8 +/- 18.3 mmHg vs. TC + CC: 120.2 +/- 15.5 mmHg, P = 0.004 and CC: 124.7 +/- 18.5 mmHg vs. CG+GG: 120.5 +/- 15.1 mmHg, P = 0.007 respectively). Comparing 213 subjects with central obesity with 213 controls matched for sex and age, rs2481084 and rs3737787 were associated with lower odds of central obesity (odds ratio = 0.516, P = 0.002 and odds ratio = 0.540, P = 0.005 respectively). All these associations remained significant after correction for multiple testing. Analysis of statistically similar SNPs suggested that the causative variants for systolic blood pressure were located in F11R, whilst those for central obesity could be due to causative variants in the transcription factor 1 gene immediately upstream.
CONCLUSIONS: F11 receptor plays a role in blood pressure regulation, not only in rats but also in man. The link between F11 receptor and central obesity merits further investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18067551     DOI: 10.1111/j.1365-2796.2007.01886.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

1.  Homophilic Interaction Between Transmembrane-JAM-A and Soluble JAM-A Regulates Thrombo-Inflammation: Implications for Coronary Artery Disease.

Authors:  Dominik Rath; Vera Rapp; Jessica Schwartz; Stefan Winter; Frederic Emschermann; Daniel Arnold; Johannes Rheinlaender; Manuela Büttcher; Michael Strebl; Michael B Braun; Konstanze Altgelt; Álvaro Petersen Uribe; Christoph Schories; Denis Canjuga; Elke Schaeffeler; Oliver Borst; Tilman E Schäffer; Harald Langer; Thilo Stehle; Matthias Schwab; Tobias Geisler; Meinrad Gawaz; Madhumita Chatterjee
Journal:  JACC Basic Transl Sci       Date:  2022-05-23

Review 2.  Structural determinants of Junctional Adhesion Molecule A (JAM-A) function and mechanisms of intracellular signaling.

Authors:  Eric A Severson; Charles A Parkos
Journal:  Curr Opin Cell Biol       Date:  2009-07-14       Impact factor: 8.382

3.  Investigation of JAM-A (rs790056) and LFA-1 (rs8058823) gene variants in Turkish colorectal cancer patients.

Authors:  Burcu Çaykara; Hani Alsaadoni; Halime Hanım Pençe; Sadrettin Pençe; Hülya Yılmaz Aydoğan; Didem Taştekin
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

4.  Investigation of the monocyte diapedesis-related LFA-1 and JAM-A gene variants in Turkish coronary heart disease patients.

Authors:  Bengu Tokat; Ozlem Kurt; Zehra Bugra; Oguz Ozturk; Hulya Yilmaz-Aydogan
Journal:  Meta Gene       Date:  2013-11-22

5.  A Common Polymorphism of Upstream Transcription Factor 1 Gene is associated with Lipid Profile: A Study in Chinese Type 2 Diabetes Families.

Authors:  Yan Song; Na Li; Liu He; Tang Xun; Dafang Chen; Yonghua Hu
Journal:  Int J Biomed Sci       Date:  2009-09

6.  Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension.

Authors:  Haibo Xu; Elizabeth B Oliveira-Sales; Fiona McBride; Beihui Liu; James Hewinson; Marie Toward; Emma B Hendy; Delyth Graham; Anna F Dominiczak; Monica Giannotta; Hidefumi Waki; Raimondo Ascione; Julian F R Paton; Sergey Kasparov
Journal:  Cardiovasc Res       Date:  2012-08-22       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.